Search Results - "Leukemia"

Possible Involvement of p38 in Mechanisms Underlying Acceleration of Proliferation by 15-Deoxy-Δ12,14-prostaglandin J2 and the Precursors in Leukemia Cell Line THP-1 by Yasutaka Azuma, Kyoko Watanabe, Masataka Date, Michiharu Daito, Kiyoshi Ohura

Connect to this object online.

Protocol and biomarker strategy for a multi-site randomized controlled trial examining biological mechanisms and dosing of active music engagement in children with acute lymphoblastic leukemia and lymphoma and parents by Sheri L. Robb, Kristen A. Russ, Steven J. Holochwost, Kristin Stegenga, Susan M. Perkins, Seethal A. Jacob, Amanda K. Henley, Jessica A. MacLean

Connect to this object online.

Treatment of persistent coronavirus disease 2019 (COVID-19) in a B cell acute lymphoblastic leukemia patient with using nirmatrelvir/ritonavir extended course: A case report by Hassan Almarhabi, Aisha Alharbi, Mai Alalawi, Mohamed Firoze Ahamed, Ihab El-Hemaidi, Nader Damfu

Connect to this object online.

Very Small Embryonic-Like Stem Cells, Endothelial Progenitor Cells, and Different Monocyte Subsets Are Effectively Mobilized in Acute Lymphoblastic Leukemia Patients after G-CSF Treatment by Andrzej Eljaszewicz, Lukasz Bolkun, Kamil Grubczak, Malgorzata Rusak, Tomasz Wasiluk, Milena Dabrowska, Piotr Radziwon, Wojciech Marlicz, Karol Kamiński, Janusz Kloczko, Marcin Moniuszko

Connect to this object online.

Routine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samples by de la Blétière Diane Raingeard, Blanchet Odile, Cornillet-Lefèbvre Pascale, Coutolleau Anne, Baranger Laurence, Geneviève Franck, Luquet Isabelle, Hunault-Berger Mathilde, Beucher Annaelle, Schmidt-Tanguy Aline, Zandecki Marc, Delneste Yves, Ifrah Norbert, Guardiola Philippe

Connect to this object online.

COST-UTILITY ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS by R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov

Connect to this object online.

Association between human T cell leukemia virus 1 (HTLV-1) infection and advanced periodontitis in relation to hematopoietic activity among elderly participants: a cross-sectional study by Yuji Shimizu, Hirotomo Yamanashi, Masayasu Kitamura, Reiko Furugen, Takahiro Iwasaki, Hideki Fukuda, Hideaki Hayashida, Koji Kawasaki, Kairi Kiyoura, Shin-Ya Kawashiri, Toshiyuki Saito, Atsushi Kawakami, Takahiro Maeda

Connect to this object online.

Standardization of 13-color high-sensitivity measurable residual disease (MRD) assessment in B-cell lymphoblastic leukemia (B-ALL) treated with novel anti-CD19 immunotherapies by Prashant Tembhare, Priyanka Dhende, Vruksha Shetty, Simpy Raj, Sitaram Ghogale, Sweta Rajpal, Gaurav Chatterjie, Karisma Girase, Nikhil Patkar, Nilesh Deshpande, Chetan Dhamane, Gaurav Narula, P.G. Subramanian

Connect to this object online.

De Novo Class of Momordicoside with Potent and Selective Tumor Cell Growth Inhibitory Activity as Pyruvate Kinase Muscle Isozyme 2 and Anti-apoptotic Myeloid Leukemia 1 Inhibitors by Tope Abraham Ibisanmi, ‪Jamiu Olaseni Aribisala, Peace Ifeoma Odjegba, Damilola Ademuyi, Ayomide Akinmusere, Faith I Ajayi

Connect to this object online.

Chapter 3 Xenotropic Murine Leukemia Virus-Related Virus as a Case Study: Using a Precautionary Risk Management Approach for Emerging Blood-Borne Pathogens in Canada by Oraby, Tamer

Subjects: “…Xenotropic murine leukemia virus-related virus…”
OAPEN Library: download the publication
OAPEN Library: description of the publication

Synthesis, characterization and cytotoxic activity of betulinic acid glucosides against human myeloid leukemia and human T-4 lymphoblastoid cell lines / Mohd Tajudin Mohd Ali and Nurhana Faujan by Mohd Ali, Mohd Tajudin, Faujan, Nurhana

Link Metadata

UJI SITOTOKSIK ISOLAT A FRAKSI SEMI POLAR EKSTRAK METANOL DARI KULIT BATANG MERANTI KUNING(Shorea accuminatissima) TERHADAP SEL MURIN LEUKEMIA P-388 by SUSANTO, SUSANTO

Connect to this object online

KEJADIAN INFEKSI PASIEN ANAK LEUKEMIA LIMFOBLASTIK AKUT PADA FASE INDUKSI DAN KONSOLIDASI DI RSUPN DR. CIPTO MANGUNKUSUMO (PERIODE JANUARI 2014-DESEMBER 2015) by Diary Arina Qonita Widowati, -

Link Metadata

Validasi Sistem Skoring Rondinelli untuk Mendeteksi Komplikasi Infeksi Berat pada Pasien Leukemia Limfoblastik Akut L1 dengan Demam Neutropenia Selama Kemoterapi Fase Induksi by Renno Hidayat, Djajadiman Gatot, Mulyadi M Djer

Connect to this object online.

Over-Expressed GATA-1_S, the Short Isoform of the Hematopoietic Transcriptional Factor GATA-1, Inhibits Ferroptosis in K562 Myeloid Leukemia Cells by Preventing Lipid Peroxidation by Silvia Trombetti, Nunzia Iaccarino, Patrizia Riccio, Raffaele Sessa, Rosa Catapano, Marcella Salvatore, Stelina Luka, Sergio de Nicola, Paola Izzo, Sante Roperto, Pasqualino Maddalena, Antonio Randazzo, Michela Grosso

Connect to this object online.

Precursor B-Cell Acute Lymphoblastic Leukemia/Lymphoma with L3 Morphology, Philadelphia Chromosome, MYC Gene Translocation, and Coexpression of TdT and Surface Light Chains: A Case Report by Alicia C. Hirzel, Aaron Cotrell, Robert Gasparini, Vathany Sriganeshan

Connect to this object online.

PHF6 functions as a tumor suppressor by recruiting methyltransferase SUV39H1 to nucleolar region and offers a novel therapeutic target for PHF6-muntant leukemia by Hsiang-i Tsai, Yanping Wu, Rui Huang, Dandan Su, Yingyi Wu, Xiaoyan Liu, Linglu Wang, Zhanxue Xu, Yuxin Pang, Chong Sun, Chao He, Fan Shu, Haitao Zhu, Dongqing Wang, Fang Cheng, Laiqiang Huang, Hongbo Chen

Connect to this object online.

Enfermedad injerto vs hospedero postransfusional en un paciente con leucemia linfoblástica aguda Graft vs host disease after transfusion in a patient with acute linfoblastic leukemia by TR Nijamin, LJ Jaime, JA Laffargue, G Cao, D Navacchia, SA Grees

Connect to this object online.

Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment by Nerea Vega-García, Nerea Vega-García, Sara Perez-Jaume, Elena Esperanza-Cebollada, Elena Esperanza-Cebollada, Clara Vicente-Garcés, Clara Vicente-Garcés, Montserrat Torrebadell, Montserrat Torrebadell, Montserrat Torrebadell, Antonio Jiménez-Velasco, Margarita Ortega, Marta Llop, Marta Llop, Lorea Abad, José Manuel Vagace, Alfredo Minguela, Marta Pratcorona, Joaquín Sánchez-Garcia, Clara B. García-Calderón, María Teresa Gómez-Casares, Estela Martín-Clavero, Adela Escudero, Marta Riñón Martinez-Gallo, Luz Muñoz, María Rosario Velasco, Marina García-Morin, Albert Català, Albert Català, Albert Català, Antonia Pascual, Pablo Velasco, José Mª. Fernández, Alvaro Lassaletta, José Luis Fuster, Isabel Badell, Águeda Molinos-Quintana, Antonio Molinés, Pilar Guerra-García, Pilar Guerra-García, Antonio Pérez-Martínez, Antonio Pérez-Martínez, Miriam García-Abós, Reyes Robles Ortiz, Sandra Pisa, Rosa Adán, Cristina Díaz de Heredia, José Luis Dapena, José Luis Dapena, Susana Rives, Susana Rives, Susana Rives, Manuel Ramírez-Orellana, Mireia Camós, Mireia Camós, Mireia Camós

Connect to this object online.

Arminin 1a-C, a novel antimicrobial peptide from ancient metazoan Hydra, shows potent antileukemia activity against drug-sensitive and drug-resistant leukemia cells by Liang X, Wang R, Dou W, Zhao L, Zhou L, Zhu J, Wang K, Yan J

Connect to this object online.